Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
VistaPharm is recalling 322,650 cups of Metoclopramide Oral Solution because the containers leak when inverted.
Astellas Pharma US Inc is recalling 9,236 bottles of Tarceva (erlotinib) 150 mg tablets because they failed routine stability testing for dissolution.
Gilead Sciences is recalling Truvada tablets because they contain small red silicone rubber particulates. The recall affects 10,317 bottles distributed nationwide.
Bracco Diagnostic Inc is recalling E-Z-GAS antacid packets because routine stability testing found the drug to be subpotent.
Eugene Oregon, Inc. is recalling Black Ant capsules because FDA testing found undeclared sildenafil. The product was marketed without an approved NDA or ANDA.
Baxter Healthcare is recalling 50,530 bags of Dianeal Low Calcium peritoneal dialysis solution due to the presence of particulate matter found during manufacturing.
Eugene Oregon, Inc. is recalling African Black Ant capsules because FDA laboratory analyses found undeclared sildenafil. The product was marketed without an approved NDA/ANDA.
Eugene Oregon, Inc. is recalling MOJO RISEN because FDA testing found undeclared sildenafil and the product was marketed without an approved NDA or ANDA.
Sagent Pharmaceuticals is recalling 10,622 bags of Zoledronic Acid Injection because of a lack of assurance of sterility and leaking premix bags.
Baxter Healthcare is recalling 11,808 bags of Dopamine Hydrochloride and Dextrose due to a potential manufacturing defect that may compromise sterility.
New England Home Therapies is recalling all sterile drugs compounded between February 21 and 24, 2014, due to a lack of assurance of sterility.
Hospira is recalling 40,730 vials of Marcaine (bupivacaine hydrochloride) injection because of a confirmed complaint of visible metal particles in the solution.
AbbVie is recalling 18,021 bottles of CREON (pancrelipase) capsules because some bottles contain foreign tablets or co-mingled LipaCreon 13000.
The FDA is recalling CUBICIN daptomycin injection vials because there may be glass particles present in the vials.
Actavis is recalling 36,538 bottles of Diclofenac Sodium and Misoprostol tablets due to complaints of split or broken tablets.
Actavis is recalling 6,041 bottles of Diclofenac Sodium and Misoprostol tablets because they may be split or broken.
Baxter Healthcare is recalling 148,632 bags of Potassium Chloride Injection because shipping cartons were incorrectly labeled and contained Gentamicin Sulfate Injection instead.
Akorn, Inc. is recalling 5,539 vials of Rifampin for Injection USP, 600 mg, because a stability test showed an impurity level exceeding specifications.
Apotex Corp. is recalling Olanzapine Orally Disintegrating Tablets 5 mg because testing showed the drug levels were below specification.
Qualitest Pharmaceuticals is recalling specific lots of Methylprednisolone 4 mg tablets because they may be subpotent due to a 6-month stability time point issue.
Noven Pharmaceuticals is recalling 160,800 Daytrana patches because the adhesive release liner may be difficult to remove.
Alvogen, Inc. is recalling 8,964 bottles of Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg because the lot failed uniformity of dosage units specifications for the oxycodone component.
Hospira Inc. is recalling specific lots of Buprenorphine Hydrochloride Injection because the product failed impurity specifications during stability testing.
Nova Products, Inc. is voluntarily recalling Black Ant capsules because FDA analysis found undeclared sildenafil, an active ingredient in erectile dysfunction drugs.
Nova Products, Inc. is voluntarily recalling XZEN GOLD capsules because FDA testing found undeclared sildenafil and tadalafil.